(1)
Assessing the Financial Immunity: A Pre- and Post-COVID Comparative Analysis of Sustainable Growth in Indian Pharmaceuticals Companies. IJMPR 2026, 5 (1), 74-81. https://doi.org/10.55829/engpv623.